Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹3,179 Cr
up ₹34.6 Cr vs Oct 2025
- Stocks held
- 29
- unchanged
- Top 10 weight
- 64.1%
- of the portfolio in its ten largest
- Cash & debt
- 2.1%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 16
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In November 2025 it disclosed 29 stocks worth ₹3,179 Cr, up ₹34.6 Cr from Oct 2025. Its largest positions were Sun Pharmaceutical Industries Limited (8.8%), Cipla Limited (8.6%), IPCA Laboratories Limited (7.8%); the ten largest together made up 64.1% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 64.5% of its equity. Cash and debt stood at 2.1%. Compared with Oct 2025 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
89%
Top-10 weight is higher than 89% of peers
Breadth
12%
Holds more stocks than 12% of peers
Cash
32%
Holds more cash than 32% of peers
Holdings in November 2025
Download CSVEvery line the fund disclosed, with the change against Oct 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 8.85%
- Δ weight
- up 0.59 pts
- Value
- ₹281 Cr
- Δ value
- up ₹21.6 Cr
- Status
- Added
- Weight
- 8.63%
- Δ weight
- up 0.08 pts
- Value
- ₹274 Cr
- Δ value
- up ₹5.4 Cr
- Status
- Added
- Weight
- 7.76%
- Δ weight
- up 0.90 pts
- Value
- ₹247 Cr
- Δ value
- up ₹30.9 Cr
- Status
- Added
- Weight
- 6.89%
- Δ weight
- up 2.31 pts
- Value
- ₹219 Cr
- Δ value
- up ₹74.9 Cr
- Status
- Added
- Weight
- 6.21%
- Δ weight
- down 0.52 pts
- Value
- ₹197 Cr
- Δ value
- down ₹14.1 Cr
- Status
- Trimmed
- Weight
- 5.93%
- Δ weight
- up 0.34 pts
- Value
- ₹189 Cr
- Δ value
- up ₹12.8 Cr
- Status
- Added
- Weight
- 5.27%
- Δ weight
- down 1.84 pts
- Value
- ₹167 Cr
- Δ value
- down ₹56.1 Cr
- Status
- Trimmed
- Weight
- 5.10%
- Δ weight
- down 0.55 pts
- Value
- ₹162 Cr
- Δ value
- down ₹15.6 Cr
- Status
- Trimmed
- Weight
- 4.99%
- Δ weight
- down 0.25 pts
- Value
- ₹159 Cr
- Δ value
- down ₹6.1 Cr
- Status
- Trimmed
- Weight
- 4.49%
- Δ weight
- down 0.26 pts
- Value
- ₹143 Cr
- Δ value
- down ₹6.7 Cr
- Status
- Trimmed
- Weight
- 4.08%
- Δ weight
- down <0.01 pts
- Value
- ₹130 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
- Weight
- 3.14%
- Δ weight
- down 0.18 pts
- Value
- ₹99.8 Cr
- Δ value
- down ₹4.7 Cr
- Status
- Trimmed
- Weight
- 3.12%
- Δ weight
- down 0.24 pts
- Value
- ₹99.1 Cr
- Δ value
- down ₹6.6 Cr
- Status
- Trimmed
- Weight
- 3.03%
- Δ weight
- up 0.20 pts
- Value
- ₹96.3 Cr
- Δ value
- up ₹7.3 Cr
- Status
- Added
- Weight
- 2.94%
- Δ weight
- down <0.01 pts
- Value
- ₹93.4 Cr
- Δ value
- up ₹88 L
- Status
- Added
- Weight
- 2.87%
- Δ weight
- down 0.26 pts
- Value
- ₹91.2 Cr
- Δ value
- down ₹7.1 Cr
- Status
- Trimmed
- Weight
- 2.61%
- Δ weight
- down 0.27 pts
- Value
- ₹82.8 Cr
- Δ value
- down ₹7.4 Cr
- Status
- Trimmed
- Weight
- 2.18%
- Δ weight
- down 0.06 pts
- Value
- ₹69.4 Cr
- Δ value
- down ₹1.3 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 2.14%
- Δ weight
- up 0.83 pts
- Value
- ₹67.9 Cr
- Δ value
- up ₹26.9 Cr
- Status
- Added
- Weight
- 1.73%
- Δ weight
- up 0.08 pts
- Value
- ₹54.9 Cr
- Δ value
- up ₹3 Cr
- Status
- Added
- Weight
- 1.50%
- Δ weight
- down 0.03 pts
- Value
- ₹47.6 Cr
- Δ value
- down ₹56 L
- Status
- Trimmed
- Weight
- 1.25%
- Δ weight
- down 0.02 pts
- Value
- ₹39.8 Cr
- Δ value
- down ₹32 L
- Status
- Trimmed
- Weight
- 1.15%
- Δ weight
- up 0.04 pts
- Value
- ₹36.4 Cr
- Δ value
- up ₹1.8 Cr
- Status
- Added
- Weight
- 1.14%
- Δ weight
- down 0.19 pts
- Value
- ₹36.2 Cr
- Δ value
- down ₹5.6 Cr
- Status
- Trimmed
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.80%
- Δ weight
- up 0.01 pts
- Value
- ₹25.4 Cr
- Δ value
- up ₹72 L
- Status
- Added
- Weight
- 0.67%
- Δ weight
- up 0.01 pts
- Value
- ₹21.2 Cr
- Δ value
- up ₹67 L
- Status
- Added
- Weight
- 0.49%
- Δ weight
- up 0.02 pts
- Value
- ₹15.5 Cr
- Δ value
- up ₹88 L
- Status
- Added
- Weight
- 0.44%
- Δ weight
- down 0.04 pts
- Value
- ₹13.9 Cr
- Δ value
- down ₹1 Cr
- Status
- Trimmed
- Weight
- 0.27%
- Δ weight
- up 0.04 pts
- Value
- ₹8.6 Cr
- Δ value
- up ₹1.5 Cr
- Status
- Added
- Weight
- 0.24%
- Δ weight
- down 0.04 pts
- Value
- ₹7.8 Cr
- Δ value
- down ₹1 Cr
- Status
- Trimmed
- Weight
- 0.12%
- Δ weight
- down 0.69 pts
- Value
- ₹3.9 Cr
- Δ value
- down ₹21.8 Cr
- Status
- Trimmed
What changed, Oct 2025 to Nov 2025
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Globus Medical Incup ₹74.9 Cr (+2.31% pts)
- IPCA Laboratories Limitedup ₹30.9 Cr (+0.90% pts)
- Sun Pharmaceutical Industries Limitedup ₹21.6 Cr (+0.59% pts)
- Illumina Incup ₹12.8 Cr (+0.34% pts)
- Intuitive Surgical Incup ₹7.3 Cr (+0.20% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Oct 2025, the weight rose most in Healthcare Equipment & Supplies (+2.6 pts), and fell most in Pharmaceuticals & Biotechnology (−1.7 pts) and Healthcare Services (−0.7 pts).
- Healthcare Equipment & Supplies7.9% → 10.5%+2.6 pts
- Pharmaceuticals & Biotechnology66.2% → 64.5%−1.7 pts
- Healthcare Services18.6% → 17.8%−0.7 pts
- Pharmaceuticals5.4% → 5.2%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Nov 2022 | Nov 2024 | May 2025 | Aug 2025 | Oct 2025 | Nov 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 61.2% | 64.2% | 66.9% | 67.3% | 66.2% | 64.5% |
| Healthcare Services | 23.2% | 18.3% | 17.2% | 17.5% | 18.6% | 17.8% |
| Healthcare Equipment & Supplies | 6.4% | 9.1% | 8.0% | 7.7% | 7.9% | 10.5% |
| Pharmaceuticals | 5.8% | 6.4% | 5.7% | 5.5% | 5.4% | 5.2% |
| Insurance | 2.4% | 1.5% | 1.5% | 1.5% | 1.6% | 1.5% |
| Retailing | 1.1% | 0.5% | 0.6% | 0.5% | 0.5% | 0.5% |
Allocation in Nov 2025change vs Oct 2025
- Pharmaceuticals & Biotechnology (14)64.5%▼ 1.7 pts
- Healthcare Services (7)17.8%▼ 0.7 pts
- Healthcare Equipment & Supplies (3)10.5%▲ 2.6 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Nov 2025
2.1%
▲ 0.8 pts vs Oct 2025
- Cash alone
- 2.1%
- cash and net receivables
- A year earlier
- 4.8%
- Nov 2024 · now ▼ 2.7 pts
- Last 12 months
- 0.1% – 2.5%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.